title: Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomes.
abstract: For individuals dependent on opioids, recovery efforts begin with a period of withdrawal that typically includes discomfort from symptoms, possibly precipitating a return to drug use. The study described here investigated whether the provision of ancillary medications for opioid withdrawal symptoms affected treatment outcomes in 139 participants receiving buprenorphine in a 13-day detoxification trial. Outcome measures include the number of opioid-free urine samples collected and retention in treatment. Ancillary medications were provided to 70% of participants: 59% received medication for insomnia, 45% for anxiety, 40% for bone pain, 35% for nausea, and 28% for diarrhea. Findings indicate no difference in the number of opioid-free urine samples between the group receiving ancillary medication and the group who did not, although tests of specific ancillary medications indicate that those who received diarrhea medication had fewer opioid-free urines than those who did not (P = .004). Results also indicate that participants attended fewer days of treatment if they received anxiety, nausea, or diarrhea medication compared to no medication (all P values < .05).
authors.affiliation: University of California, Los Angeles, Integrated Substance Abuse Programs, Los Angeles, CA 90025, USA. hillhous@ucla.edu
authors.forename: Maureen
authors.initials: M
authors.lastname: Hillhouse
authors.forename: Catherine P
authors.initials: CP
authors.lastname: Domier
authors.forename: David
authors.initials: D
authors.lastname: Chim
authors.forename: Walter
authors.initials: W
authors.lastname: Ling
mesh_terms: D000328:Adult; D000701:Analgesics, Opioid / Q000493:pharmacokinetics* / Q000652:urine; D001007:Anxiety / Q000139:chemically induced / Q000188:drug therapy; D002047:Buprenorphine / Q000627:therapeutic use*; D003967:Diarrhea / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D006801:Humans; D008658:Inactivation, Metabolic; D008297:Male; D008875:Middle Aged; D009294:Narcotics / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy; D009293:Opioid-Related Disorders / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D010146:Pain / Q000139:chemically induced / Q000188:drug therapy; D017465:Receptors, Opioid, delta / Q000037:antagonists & inhibitors*; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000701:Analgesics, Opioid; D009294:Narcotics; D017465:Receptors, Opioid, delta; D002047:Buprenorphine
references.citation: Addiction. 1998 Apr;93(4):475-86
references.pmid: 9684386
references.citation: Am J Psychiatry. 2001 Aug;158(8):1200-4
references.pmid: 11481150
references.citation: Am J Drug Alcohol Abuse. 2007;33(5):643-54
references.pmid: 17891657
references.citation: N Engl J Med. 2008 Jun 5;358(23):2482-94
references.pmid: 18525044
references.citation: Drug Alcohol Depend. 2000 Feb 1;58(1-2):143-52
references.pmid: 10669065
references.citation: J Pharmacol Exp Ther. 1988 Oct;247(1):47-53
references.pmid: 2459370
references.citation: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003409
references.pmid: 16034898
references.citation: JAMA. 2000 Dec 20;284(23):3043-5
references.pmid: 11122593
references.citation: J Subst Abuse Treat. 1992;9(3):199-213
references.pmid: 1334156
references.citation: Addiction. 2005 Aug;100(8):1090-100
references.pmid: 16042639
references.citation: Arch Gen Psychiatry. 1996 May;53(5):401-7
references.pmid: 8624183
references.citation: J Psychoactive Drugs. 2003 Apr-Jun;35(2):253-9
references.pmid: 12924748
references.citation: J Subst Abuse Treat. 2004 Sep;27(2):153-9
references.pmid: 15450648
references.citation: Clin Pharmacol Ther. 1988 Jan;43(1):72-8
references.pmid: 3275523
references.citation: Drug Alcohol Depend. 1998 Mar 1;50(1):1-8
references.pmid: 9589267
references.citation: J Subst Abuse Treat. 2002 Oct;23(3):163-9
references.pmid: 12392802
references.citation: Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S49-57
references.pmid: 12738350